GlassScriptPhysician profile
John G Vangilder
NPI 1437233269
$7,805.19
in general payments reported to CMS, 2019-2025
8 companies · $4,717 in 2025
The $4,717 reported for 2025 was more than what 80% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $475 · 2020: $330 · 2021: $701 · 2022: $165 · 2023: $117 · 2024: $1,300 · 2025: $4,717.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,136 · Food and Beverage: $998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,136.44 |
| Food and Beverage | $997.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $4,643.93 | 2025 | Excelsius Gps, Creo, Colonial |
| Medtronic, INC. | $1,994.55 | 2021-2024 | Stealthstation S8 Platform, Adaptix Interbody System With Titan Nanolock Surface Technology, Anteralign Spinal System With Titan Nanolock Surface Technology |
| Medtronic USA, INC. | $749.51 | 2019-2020 | |
| Boston Scientific Corporation | $157.09 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Pacira Pharmaceuticals Incorporated | $92.64 | 2021 | |
| Livanova USA, INC. | $83.38 | 2024-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Nevro Corp. | $46.24 | 2021 | |
| Abbott Laboratories | $37.85 | 2023 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Vangilder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.